D

Aclaris Therapeutics, Inc. ACRS

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$3.40$3.55
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Net Income 43.79% 43.75% 46.50% 50.84% -282.88%
Total Depreciation and Amortization -16.97% -25.35% -38.15% -43.74% -44.51%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -88.06% -87.63% -85.84% -85.35% 1,530.95%
Change in Net Operating Assets -407.00% -96.58% -83.43% -75.54% -106.18%
Cash from Operations -75.23% -521.34% -323.85% -134.68% -139.80%
Capital Expenditure -24.14% -84.38% -179.31% 8.26% 84.52%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 14.28% 105.91% 97.62% 169.60% -287.10%
Cash from Investing 14.21% 105.72% 97.50% 169.32% -291.39%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 45.92% -27.35% -27.49% -- 8,720.29%
Repurchase of Common Stock 19.29% 30.62% 33.07% -9.05% -711.84%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 70.83% -6.47% -6.47% -6.47% -884.38%
Cash from Financing 59.80% -29.63% -29.77% -107.86% 1,424,940.00%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 78.29% -342.80% 69.06% 69.89% -360.07%